Acquired risk factors for deep-vein thrombosis in symptomatic outpatients
- PMID: 8285811
Acquired risk factors for deep-vein thrombosis in symptomatic outpatients
Abstract
Background: Epidemiologic studies on deep-vein thrombosis (DVT) have been mainly confined to the inpatient population. The aim of this study was to investigate the association between DVT and acquired risk factors in a large cohort of outpatients with clinically suspected DVT.
Methods: Consecutive outpatients with clinically suspected DVT were enrolled in the study. Before objective testing, all patients were interviewed by a trained physician for the presence of risk factors for DVT development. Subsequently, the presence or absence of DVT was assessed with venography.
Results: Approximately 50% of cases of DVT were considered to be secondary to a major risk factor (immobilization, trauma, and/or recent surgery). Among additional risk factors, only increased age (over 60 years), male gender, malignant neoplasm, heart failure, systemic lupus erythematosus, and arteriopathy were independently associated with the risk of acute DVT.
Conclusion: Major risk factors for venous thromboembolism are a common cause of DVT among symptomatic outpatients; therefore, the usefulness of extending DVT prophylaxis in the outpatient setting should be tested. The role of additional risk factors in the development of DVT needs to be established by properly designed studies.
Similar articles
-
The value of a risk factor analysis in clinically suspected deep venous thrombosis.Respiration. 1997;64(5):326-30. doi: 10.1159/000196699. Respiration. 1997. PMID: 9311047 Clinical Trial.
-
The factor VR506Q mutation causing APC resistance is highly prevalent amongst unselected outpatients with clinically suspected deep venous thrombosis.J Intern Med. 1997 May;241(5):379-85. doi: 10.1046/j.1365-2796.1997.124140000.x. J Intern Med. 1997. PMID: 9183305
-
Deep venous thrombosis and lupus anticoagulant. A case-control study.Thromb Haemost. 1996 Aug;76(2):187-9. Thromb Haemost. 1996. PMID: 8865528
-
Current role of venography in the diagnosis of deep-vein thrombosis.Minerva Cardioangiol. 1998 Dec;46(12):507-14. Minerva Cardioangiol. 1998. PMID: 10209941 Review.
-
Prevalence of deep venous thrombosis in patients with chronic spinal cord injury.Arch Phys Med Rehabil. 1994 Sep;75(9):965-8. Arch Phys Med Rehabil. 1994. PMID: 8085931 Review.
Cited by
-
Risk of site-specific cancer in incident venous thromboembolism: a population-based study.Thromb Res. 2015 Mar;135(3):472-8. doi: 10.1016/j.thromres.2014.12.013. Epub 2014 Dec 16. Thromb Res. 2015. PMID: 25547213 Free PMC article.
-
Venous thromboembolic disease.Ochsner J. 2002 Winter;4(1):6-8. Ochsner J. 2002. PMID: 22822307 Free PMC article.
-
Hybrid carbon-based scaffolds for applications in soft tissue reconstruction.Tissue Eng Part A. 2012 May;18(9-10):946-56. doi: 10.1089/ten.TEA.2011.0533. Epub 2012 Feb 28. Tissue Eng Part A. 2012. PMID: 22092333 Free PMC article.
-
Epidemiology of venous thromboembolism.Nat Rev Cardiol. 2015 Aug;12(8):464-74. doi: 10.1038/nrcardio.2015.83. Epub 2015 Jun 16. Nat Rev Cardiol. 2015. PMID: 26076949 Free PMC article. Review.
-
Rivaroxaban Pharmacokinetics in Obese Subjects: A Systematic Review.Clin Pharmacokinet. 2022 Dec;61(12):1677-1695. doi: 10.1007/s40262-022-01160-z. Epub 2022 Oct 6. Clin Pharmacokinet. 2022. PMID: 36201149 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources